Arcutis Biotherapeutics
ARQT
ARQT
56 hedge funds and large institutions have $1.02B invested in Arcutis Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
11
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$47.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$11.4M |
3 |
3
Wells Fargo
San Francisco,
California
|
$15.9M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$4.6M |
5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$32.3M |